$Tesla (TSLA.US)$
Canceling subsidies: will only be bullish for Tesla. The reason is simple, there are only two electric vehicle companies in the world that are truly profitable, one is BYD and the other is Tesla, with BYD relying mostly on hybrid vehicle profits. Canceling subsidies in the USA will only cause the already loss-making American electric vehicle companies to incur even greater losses, leading to the inability to sustain their businesses and resulting in closure. With a more limited choice of electric vehicles, who do you think people will choose? If the cancellation of subsidies coincides with Tesla's launch of affordable models next year, it will only bring more benefits to Tesla.
Products: Tesla is not just an electric vehicle company, many people are not aware of this. It has a new energy business, autonomous driving software FSD licensing, self-driving taxis (not yet launched), Supercharger licensing, Cybertruck, humanoid robots (not yet launched), and supercomputer Dojo cluster leasing, etc. What do you mean by not having a diversified product portfolio?
Tesla excels in safety evaluations of all its vehicles, exuding a strong sense of technology, and its greatest potential has yet to be fully realized, namely the Musk ecosystem. So, it can only be said that those who cannot see the bigger picture, have a myopic view, should sell off all their Tesla stocks and invest in other stocks.

$Riot Platforms (RIOT.US)$ with the having taking place and bitcoins price sitting below 60,000 if you do not see 75 to $80,000 average price this quarter then the revenues for Bitcoin Mara clean spark are going to drop precipitously down 30 to 40% minimum this quarter and through the balance of the year. why anybody would want to own a company that the underlying commodity is declining in price and becoming twice as difficult to mine is beyond me. if you have a company that misses revenue by one...

$Madrigal Pharmaceuticals (MDGL.US)$ Are we days away from the 1st approved NASH/MASH therapy? 🤞
• After decades of trial and error in the field!
Resmetirom $MDGL for treating NASH/MASH 🧑‍🔬
• PDUFA date 3/14! 🗓️
• Impressive data
⇒ Ph3 MAESTRO-NASH trial
⇒ Met both key NASH endpoints - Fibrosis & NASH 📸 👇
⇒ Granted breakthrough therapy designation & priority review
⇒ Once daily, oral 💊
⇒ THR-β agonist
⇒ MDGL has run up into PDUFA... 📸 👇

$MicroStrategy (MSTR.US)$ Didn't it pass? Is it true news?

$Riot Platforms (RIOT.US)$ What in the hell? Should be up with Bitcoin. Such manipulation!

$MARA Holdings (MARA.US)$ So weak.